Background on Colorectal Cancer Screening and its Role in Patient Care

Opinion
Video

Arvind Dasari, MD, MS, outlines the evolution of colorectal cancer screening, addressing historical challenges, and the development of non-invasive screening techniques.

  1. Dr Dasari: Please describe the importance and a brief history of CRC screening
    1. What are some challenges traditionally associated with CRC screening?
      1. Do these challenges vary between academic and community settings?
    2. How have noninvasive screening methods and age recommendations evolved over time?
      1. Please briefly mention the variety of sources (stool, blood, tissue, etc.) and methods that have become available
Related Videos
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
This series features 2 KOLs.
This series features 2 KOLs.
4 KOLs are featured in this panel.
4 KOLs are featured in this program.
4 KOLs are featured in this program.
2 KOLs are featured in this series
2 KOLs are featured in this series
Video 1 - 4 KOLs are featured in "Triaging and Prioritizing Patients with Multiple Myeloma"
Related Content
The EA2201 trial assessed nivolumab plus ipilimumab and short-course radiation therapy for patients with locally advanced rectal cancer.

Nivolumab/Ipilimumab Plus RT Shows Promise in Locally Advanced Rectal Cancer

Ariana Pelosci
July 1st 2024
Article

The EA2201 trial assessed nivolumab plus ipilimumab and short-course radiation therapy for patients with locally advanced rectal cancer.

Oncology pharmacist Jagoda Misniakiewicz, PharmD, discusses the potential efficacy and safety profile of fruquintinib in patients with metastatic CRC.

Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval

Jagoda Misniakiewicz, PharmD
June 10th 2024
Podcast

Oncology pharmacist Jagoda Misniakiewicz, PharmD, discusses the potential efficacy and safety profile of fruquintinib in patients with metastatic CRC.

Data from FRESCO-2 support the approval of fruquintinib for those with previously treated metastatic colorectal cancer in the European Union.

European Commission Approves Fruquintinib in Pretreated Metastatic CRC

Russ Conroy
June 24th 2024
Article

Data from FRESCO-2 support the approval of fruquintinib for those with previously treated metastatic colorectal cancer in the European Union.

Surgical oncologists from Cleveland Clinic discuss the National Accreditation Program for Rectal Cancer and its aim to improve patient outcomes.

Ensuring Quality Rectal Cancer Surgery at NAPRC-Accredited Institutions

Steven Wexner, MD, PhD;Arielle Kanters, MD
May 27th 2024
Podcast

Surgical oncologists from Cleveland Clinic discuss the National Accreditation Program for Rectal Cancer and its aim to improve patient outcomes.

Phase 2 data show that vaccination with PolyPEPI1018 may enhance the efficacy of atezolizumab in those with microsatellite stable metastatic CRC.

Multi-Peptide Vaccine Combo Shows Tolerability in Metastatic MSS CRC

Russ Conroy
June 3rd 2024
Article

Phase 2 data show that vaccination with PolyPEPI1018 may enhance the efficacy of atezolizumab in those with microsatellite stable metastatic CRC.

5-Year OS Rates Improve After Liver Transplant Plus Chemo CRC With Liver Metastasis

5-Year OS Rates Improve After Liver Transplant Plus Chemo CRC With Liver Metastasis

Caroline Seymour
June 2nd 2024
Article

The addition of liver transplant to chemotherapy in those with colorectal cancer and liver metastases boosted overall survival.